TLR9 and MyD88 are crucial for the development of protective immunity to malaria

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 5073-5085

  Gowda, Nagaraj M ^a   Wu, Xianzhu ^a   Gowda, D Channe ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LEVEL; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DISEASE PREDISPOSITION; ENZYME REGULATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; INFECTION CONTROL; INFECTION RESISTANCE; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TH1 CELL; TH2 CELL;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MALARIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM YOELII; SURVIVAL RATE; TOLL-LIKE RECEPTOR 9;

EID: 84861159419     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102143     Document Type: Article

References (74)

1. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217. (Pubitemid 40388051)
2. Stevenson, M. M., and E. M. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4: 169-180. (Pubitemid 38339083)
3. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5: 722-735. (Pubitemid 43086173)
4. Riley, E. M., S. Wahl, D. J. Perkins, and L. Schofield. 2006. Regulating immunity to malaria. Parasite Immunol. 28: 35-49.
5. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499. (Pubitemid 37088152)
6. Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7: 179-190.
7. Akira, S. 2009. Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunol. Rev. 227: 5-8.
8. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
9. Blasius, A. L., and B. Beutler. 2010. Intracellular Toll-like receptors. Immunity 32: 305-315.
10. Krishnegowda, G., A. M. Hajjar, J. Zhu, E. J. Douglass, S. Uematsu, S. Akira, A. S. Woods, and D. C. Gowda. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280: 8606-8616. (Pubitemid 40349765)
11. Figueiredo, R. T., P. L. Fernandez, D. S. Mourao-Sa, B. N. Porto, F. F. Dutra, L. S. Alves, M. F. Oliveira, P. L. Oliveira, A. V. Graça-Souza, and M. T. Bozza. 2007. Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282: 20221-20229. (Pubitemid 47100035)
12. Couper, K. N., T. Barnes, J. C. Hafalla, V. Combes, B. Ryffel, T. Secher, G. E. Grau, E. M. Riley, and J. B. de Souza. 2010. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog. 6: e1000744.
13. Pichyangkul, S., K. Yongvanitchit, U. Kum-arb, H. Hemmi, S. Akira, A. M. Krieg, D. G. Heppner, V. A. Stewart, H. Hasegawa, S. Looareesuwan, et al. 2004. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172: 4926-4933. (Pubitemid 38456417)
14. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104: 1919-1924. (Pubitemid 46239879)
15. Wu, X., N. M. Gowda, S. Kumar, and D. C. Gowda. 2010. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J. Immunol. 184: 4338-4348.
16. Yarovinsky, F., D. Zhang, J. F. Andersen, G. L. Bannenberg, C. N. Serhan, M. S. Hayden, S. Hieny, F. S. Sutterwala, R. A. Flavell, S. Ghosh, and A. Sher. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629. (Pubitemid 40807512)
17. Kursula, I., P. Kursula, M. Ganter, S. Panjikar, K. Matuschewski, and H. Schüler. 2008. Structural basis for parasite-specific functions of the divergent profilin of Plasmodium falciparum. Structure 16: 1638-1648.
18. Franklin, B. S., S. O. Rodrigues, L. R. Antonelli, R. V. Oliveira, A. M. Goncalves, P. A. Sales-Junior, E. P. Valente, J. I. Alvarez-Leite, C. Ropert, D. T. Golenbock, and R. T. Gazzinelli. 2007. MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect. 9: 881-890. (Pubitemid 46891856)
19. Coban, C., K. J. Ishii, S. Uematsu, N. Arisue, S. Sato, M. Yamamoto, T. Kawai, O. Takeuchi, H. Hisaeda, T. Horii, and S. Akira. 2007. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19: 67-79. (Pubitemid 46017889)
20. Seixas, E., J. F. Moura Nunes, I. Matos, and A. Coutinho. 2009. The interaction between DC and Plasmodium berghei/chabaudi-infected erythrocytes in mice involves direct cell-to-cell contact, internalization and TLR. Eur. J. Immunol. 39: 1850-1863.
21. Fritz, J. H., R. L. Ferrero, D. J. Philpott, and S. E. Girardin. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7: 1250-1257. (Pubitemid 46111242)
22. Griffith, J. W., T. Sun, M. T. McIntosh, and R. Bucala. 2009. Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J. Immunol. 183: 5208-5220.
23. Shio, M. T., S. C. Eisenbarth, M. Savaria, A. F. Vinet, M. J. Bellemare, K. W. Harder, F. S. Sutterwala, D. S. Bohle, A. Descoteaux, R. A. Flavell, and M. Olivier. 2009. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 5: e1000559.
24. Wilson, N. S., and J. A. Villadangos. 2005. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 86: 241-305. (Pubitemid 40215695)
25. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311: 17-58. (Pubitemid 47413194)
26. López-Bravo, M., and C. Ardavín. 2008. In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 29: 343-351.
27. Perry, J. A., C. S. Olver, R. C. Burnett, and A. C. Avery. 2005. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 174: 5921-5925. (Pubitemid 40663776)
28. Villadangos, J. A., and P. Schnorrer. 2007. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7: 543-555. (Pubitemid 46987783)
29. Pulendran, B., H. Tang, and S. Manicassamy. 2010. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat. Immunol. 11: 647-655.
30. Babu, S., C. P. Blauvelt, V. Kumaraswami, and T. B. Nutman. 2006. Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J. Immunol. 176: 3885-3889. (Pubitemid 44264362)
31. Dasari, P., I. C. Nicholson, G. Hodge, G. W. Dandie, and H. Zola. 2005. Expression of Toll-like receptors on B lymphocytes. Cell. Immunol. 236: 140-145. (Pubitemid 41771098)
32. Hou, B., P. Saudan, G. Ott, M. L. Wheeler, M. Ji, L. Kuzmich, L. M. Lee, R. L. Coffman, M. F. Bachmann, and A. L. DeFranco. 2011. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 34: 375-384.
33. LaRosa, D. F., J. S. Stumhofer, A. E. Gelman, A. H. Rahman, D. K. Taylor, C. A. Hunter, and L. A. Turka. 2008. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 105: 3855-3860. (Pubitemid 351723489)
34. Quigley, M., J. Martinez, X. Huang, and Y. Yang. 2009. A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood 113: 2256-2264.
35. Rahman, A. H., R. Zhang, C. D. Blosser, B. Hou, A. L. Defranco, J. S. Maltzman, E. J. Wherry, and L. A. Turka. 2011. Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88. Blood 117: 3123-3130.
36. Zhou, S., E. A. Kurt-Jones, A. M. Cerny, M. Chan, R. T. Bronson, and R. W. Finberg. 2009. MyD88 intrinsically regulates CD4 T-cell responses. J. Virol. 83: 1625-1634.
37. Barr, T. A., S. Brown, P. Mastroeni, and D. Gray. 2009. B cell intrinsic MyD88 signals drive IFN-γ production from T cells and control switching to IgG2c. J. Immunol. 183: 1005-1012.
38. Kang, S. M., D. G. Yoo, M. C. Kim, J. M. Song, M. K. Park, E. O., F. S. Quan, S. Akira, and R. W. Compans. 2011. MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J. Virol. 85: 11391-11400.
39. Gowda, N. M., X. Wu, and D. C. Gowda. 2011. The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. PLoS One 6: e20398.
40. Brasel, K., T. De Smedt, J. L. Smith, and C. R. Maliszewski. 2000. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96: 3029-3039.
41. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
42. Baran, K., A. Ciccone, C. Peters, H. Yagita, P. I. Bird, J. A. Villadangos, and J. A. Trapani. 2006. Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells. J. Biol. Chem. 281: 30485-30491. (Pubitemid 44582105)
43. Piontek, G. E., K. Taniguchi, H. G. Ljunggren, A. Grönberg, R. Kiessling, G. Klein, and K. Kärre. 1985. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J. Immunol. 135: 4281-4288. (Pubitemid 16250426)
44. Sinniah, R., L. Rui-Mei, and A. U. Kara. 1999. Up-regulation of cytokines in glomerulonephritis associated with murine malaria infection. Int. J. Exp. Pathol. 80: 87-95. (Pubitemid 29197274)
45. Watford, W. T., M. Moriguchi, A. Morinobu, and J. J. O'Shea. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14: 361-368. (Pubitemid 37099449)
46. Cederholm, A., and J. Frostegård. 2007. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann. N. Y. Acad. Sci. 1108: 96-103. (Pubitemid 47528722)
47. Schlaepfer, D. D., J. Jones, and H. T. Haigler. 1992. Inhibition of protein kinase C by annexin V. Biochemistry 31: 1886-1891.
48. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752. (Pubitemid 26324129)
49. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10: 1593-1598. (Pubitemid 28502373)
50. Caligiuri, G., S. Kaveri, and A. Nicoletti. 2005. When interleukin-18 conducts, the Preludio sounds the same no matter who plays. Arterioscler. Thromb. Vasc. Biol. 25: 655-657. (Pubitemid 40463850)
51. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364. (Pubitemid 46674493)
52. Urban, B. C., D. J. Ferguson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn, and D. J. Roberts. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400: 73-77. (Pubitemid 29315113)
53. Urban, B. C., N. Willcox, and D. J. Roberts. 2001. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98: 8750-8755. (Pubitemid 32678099)
54. Elliott, S. R., T. P. Spurck, J. M. Dodin, A. G. Maier, T. S. Voss, F. Yosaatmadja, P. D. Payne, G. I. McFadden, A. F. Cowman, S. J. Rogerson, et al. 2007. Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect. Immun. 75: 3621-3632. (Pubitemid 47040965)
55. Wang, T., H. Fujioka, J. A. Drazba, and T. Y. Sam-Yellowe. 2006. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge. Parasitol. Res. 99: 238-252. (Pubitemid 44015107)
56. Tangteerawatana, P., S. Krudsood, K. Chalermrut, S. Looareesuwan, and S. Khusmith. 2001. Natural human IgG subclass antibodies to Plasmodium falciparum blood stage antigens and their relation to malaria resistance in an endemic area of Thailand. Southeast Asian J. Trop. Med. Public Health 32: 247-254. (Pubitemid 33641772)
57. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73: 209-212. (Pubitemid 36158295)
58. Lefeber, D. J., B. Benaissa-Trouw, J. F. Vliegenthart, J. P. Kamerling, W. T. Jansen, K. Kraaijeveld, and H. Snippe. 2003. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3. Infect. Immun. 71: 6915-6920. (Pubitemid 37475322)
59. Franklin, B. S., S. T. Ishizaka, M. Lamphier, F. Gusovsky, H. Hansen, J. Rose, W. Zheng, M. A. Ataíde, R. B. de Oliveira, D. T. Golenbock, and R. T. Gazzinelli. 2011. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc. Natl. Acad. Sci. USA 108: 3689-3694.
60. Cramer, J. P., B. Lepenies, F. Kamena, C. Hölscher, M. A. Freudenberg, G. D. Burchard, H. Wagner, C. J. Kirschning, X. Liu, P. H. Seeberger, and T. Jacobs. 2008. MyD88/IL-18-dependent pathways rather than TLRs control early parasitaemia in non-lethal Plasmodium yoelii infection. Microbes Infect. 10: 1259-1265.
61. Ferguson, M. A. 1999. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J. Cell Sci. 112: 2799-2809. (Pubitemid 29430025)
62. Naik, R. S., O. H. Branch, A. S. Woods, M. Vijaykumar, D. J. Perkins, B. L. Nahlen, A. A. Lal, R. J. Cotter, C. E. Costello, C. F. Ockenhouse, et al. 2000. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192: 1563-1576.
63. Plattner, F., F. Yarovinsky, S. Romero, D. Didry, M. F. Carlier, A. Sher, and D. Soldati-Favre. 2008. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 3: 77-87. (Pubitemid 351201784)
64. Chaisavaneeyakorn, S., C. Othoro, Y. P. Shi, J. Otieno, S. C. Chaiyaroj, A. A. Lal, and V. Udhayakumar. 2003. Relationship between plasma interleukin- 12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya. Clin. Diagn. Lab. Immunol. 10: 362-366. (Pubitemid 36592960)
65. Kojima, S., Y. Nagamine,M. Hayano, S. Looareesuwan, and K. Nakanishi. 2004. A potential role of interleukin 18 in severe falciparummalaria. Acta Trop. 89: 279-284. (Pubitemid 38117064)
66. Torre, D. 2009. Early production of gamma-interferon in clinical malaria: role of interleukin-18 and interleukin-12. Clin. Infect. Dis. 48: 1481-1482.
67. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390. (Pubitemid 28188898)
68. Heidemann, S. C., V. Chavez, C. J. Landers, T. Kucharzik, J. L. Prehn, and S. R. Targan. 2010. TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets. J. Clin. Immunol. 30: 531-538.
69. Xu, D., W. L. Chan, B. P. Leung, D. Hunter, K. Schulz, R. W. Carter, I. B. McInnes, J. H. Robinson, and F. Y. Liew. 1998. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188: 1485-1492. (Pubitemid 28489585)
70. Yoshimoto, T., K. Takeda, T. Tanaka, K. Ohkusu, S. Kashiwamura, H. Okamura, S. Akira, and K. Nakanishi. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J. Immunol. 161: 3400-3407.
71. Hoffman, S. L., J. M. Crutcher, S. K. Puri, A. A. Ansari, F. Villinger, E. D. Franke, P. P. Singh, F. Finkelman, M. K. Gately, G. P. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med. 3: 80-83. (Pubitemid 27019146)
72. Su, Z., and M. M. Stevenson. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168: 1348-1355. (Pubitemid 34094505)
73. Singh, R. P., S. Kashiwamura, P. Rao, H. Okamura, A. Mukherjee, and V. S. Chauhan. 2002. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. J. Immunol. 168: 4674-4681. (Pubitemid 34441375)
74. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12: 53-72. (Pubitemid 32294587)